Resectable Pancreatic Adenocarcinoma clinical trials

Explore recruiting resectable pancreatic adenocarcinoma clinical trials.

Recruiting resectable pancreatic adenocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Resectable Pancreatic Adenocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SURVIVAL ANALYSIS AFTER NEOADJUVANT TREATMENT IN RESECTABLE PANCREATIC CANCER WITH RISK FACTORS

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Preoperative treatment with mFOLFIRINOX (or Gem-Nab-P) +/- isotoxic high-dose Stereotactic Body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma: a randomised comparative multicentre phase II study (STEREOPAC)

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

RR001 in Combination with Chemotherapy for Patients with Locally Advanced Pancreatic Adenocarcinoma: Open-label, Non-randomized Dose Escalation Phase I/IIa Study

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Resectable Pancreatic Adenocarcinoma trials by city

Resectable Pancreatic Adenocarcinoma in Toronto Resectable Pancreatic Adenocarcinoma in Vancouver Resectable Pancreatic Adenocarcinoma in Montreal Resectable Pancreatic Adenocarcinoma in Calgary Resectable Pancreatic Adenocarcinoma in Edmonton Resectable Pancreatic Adenocarcinoma in Ottawa Resectable Pancreatic Adenocarcinoma in Winnipeg Resectable Pancreatic Adenocarcinoma in Quebec City Resectable Pancreatic Adenocarcinoma in Hamilton Resectable Pancreatic Adenocarcinoma in Kitchener Resectable Pancreatic Adenocarcinoma in London Resectable Pancreatic Adenocarcinoma in Halifax Resectable Pancreatic Adenocarcinoma in New York Resectable Pancreatic Adenocarcinoma in Los Angeles Resectable Pancreatic Adenocarcinoma in Chicago Resectable Pancreatic Adenocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease